QUILIZUMAB
UNII 26F96HRJ3W

Substance Identification & Data

This profile provides standardized clinical and technical data for Quilizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 26F96HRJ3W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1228538-47-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

26F96HRJ3W

CAS Registry Number

1228538-47-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

QUILIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152116

National Cancer Institute reference terminology for clinical and research data.

INN ID

9541

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-120

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Quilizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

QUILIZUMAB

Common Names & Synonyms

QUILIZUMAB [INN]

QUILIZUMAB [USAN]

QUILIZUMAB [WHO-DD]

Systematic Nomenclature

HUMANIZED-MOUSE AFUCOSYLATED IGG1(.KAPPA.) AGAINST M1 PRIME SEGMENT OF MEMBRANE-BOUND IGE

SYS

IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E M1' FRAGMENT) (HUMAN-MOUSE MONOCLONAL MEMP1972A HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MEMP1972A LIGHT CHAIN, DIMER

SYS